These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35153625)

  • 1. SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma.
    Wang B; Sun Y
    Pathol Oncol Res; 2022; 28():1610047. PubMed ID: 35153625
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
    Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
    Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARHGAP44 expression is associated with the metastasis of osteosarcoma and is a promising prognostic biomarker.
    Hu S; Wang W
    J Orthop Res; 2023 Jun; 41(6):1348-1355. PubMed ID: 36317850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-related genes-based prognostic signature for osteosarcoma.
    Yang F; Zhang Y
    Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma.
    Zheng S; Liu Y; Sun H; Jia J; Wu T; Ding R; Cheng X
    Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34474553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration.
    Du X; Zhang Q; Wang S; Chen X; Wang Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24214. PubMed ID: 34961985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Pathogenic Genes and Transcription Factors in Osteosarcoma.
    Yang C; Huang D; Ma C; Ren J; Fu L; Cheng C; Li B; Shi X
    Pathol Oncol Res; 2020 Apr; 26(2):1041-1048. PubMed ID: 30982140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC19A1 May Serve as a Potential Biomarker for Diagnosis and Prognosis in Osteosarcoma.
    Li C; Yuan B; Yu X; Ju L; Ma Y; Guo D; Zhang K
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
    Tian W; Li Y; Zhang J; Li J; Gao J
    Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
    Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
    BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
    Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
    Front Immunol; 2022; 13():994034. PubMed ID: 36225939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of CD133 expression in patients with osteosarcoma.
    Xu N; Kang Y; Wang W; Zhou J
    Clin Exp Med; 2020 May; 20(2):261-267. PubMed ID: 32048073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mislocalized cytoplasmic p27 activates PAK1-mediated metastasis and is a prognostic factor in osteosarcoma.
    Chen X; Cates JMM; Du YC; Jain A; Jung SY; Li XN; Hicks JM; Man TK
    Mol Oncol; 2020 Apr; 14(4):846-864. PubMed ID: 31872963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for metastatic osteosarcoma biomarkers with a DNA microarray.
    Diao CY; Guo HB; Ouyang YR; Zhang HC; Liu LH; Bu J; Wang ZH; Xiao T
    Asian Pac J Cancer Prev; 2014; 15(4):1817-22. PubMed ID: 24641415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.